Form 4: UNITED THERAPEUTICS CEO Sells Shares
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on August 19, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $135.42 ($1,286,490) on August 19, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 240 Common Stock at $522.49 ($125,397) on August 19, 2026; holds 333,703 after (Indirect).
- Open-market sale: disposed of 1,264 Common Stock at $523.65 ($661,888) on August 19, 2026; holds 332,439 after (Indirect).
- Open-market sale: disposed of 441 Common Stock at $524.51 ($231,309) on August 19, 2026; holds 331,998 after (Indirect).
- Open-market sale: disposed of 895 Common Stock at $525.60 ($470,409) on August 19, 2026; holds 331,103 after (Indirect).
- Open-market sale: disposed of 2,105 Common Stock at $526.76 ($1,108,837) on August 19, 2026; holds 328,998 after (Indirect).
- Open-market sale: disposed of 2,135 Common Stock at $527.58 ($1,126,375) on August 19, 2026; holds 326,863 after (Indirect).
- Open-market sale: disposed of 1,200 Common Stock at $528.59 ($634,305) on August 19, 2026; holds 325,663 after (Indirect).
- Open-market sale: disposed of 659 Common Stock at $529.56 ($348,979) on August 19, 2026; holds 325,004 after (Indirect).
- Open-market sale: disposed of 201 Common Stock at $531.01 ($106,732) on August 19, 2026; holds 324,803 after (Indirect).
- Open-market sale: disposed of 80 Common Stock at $531.62 ($42,530) on August 19, 2026; holds 324,723 after (Indirect).
- Open-market sale: disposed of 200 Common Stock at $532.63 ($106,526) on August 19, 2026; holds 324,523 after (Indirect).
- Open-market sale: disposed of 80 Common Stock at $535.22 ($42,817) on August 19, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on August 19, 2026; holds 103,910 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $5,006,104 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-19 | Option exercise/conversion | Common Stock | 9,500 | $135 | $1.3M | 333,943 |
| 2026-08-19 | Open-market sale | Common Stock | 240 | $522 | $125.4K | 333,703 |
| 2026-08-19 | Open-market sale | Common Stock | 1,264 | $524 | $661.9K | 332,439 |
| 2026-08-19 | Open-market sale | Common Stock | 441 | $525 | $231.3K | 331,998 |
| 2026-08-19 | Open-market sale | Common Stock | 895 | $526 | $470.4K | 331,103 |
| 2026-08-19 | Open-market sale | Common Stock | 2,105 | $527 | $1.1M | 328,998 |
| 2026-08-19 | Open-market sale | Common Stock | 2,135 | $528 | $1.1M | 326,863 |
| 2026-08-19 | Open-market sale | Common Stock | 1,200 | $529 | $634.3K | 325,663 |
| 2026-08-19 | Open-market sale | Common Stock | 659 | $530 | $349.0K | 325,004 |
| 2026-08-19 | Open-market sale | Common Stock | 201 | $531 | $106.7K | 324,803 |
| 2026-08-19 | Open-market sale | Common Stock | 80 | $532 | $42.5K | 324,723 |
| 2026-08-19 | Open-market sale | Common Stock | 200 | $533 | $106.5K | 324,523 |
| 2026-08-19 | Open-market sale | Common Stock | 80 | $535 | $42.8K | 324,443 |
| 2026-08-19 | Option exercise/conversion | Stock Option | 9,500 | — | — | 103,910 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-19 | Option exercise/conversion (9,500 shares) |
| 2026-08-19 | Open-market sale (240 shares) |
| 2026-08-19 | Open-market sale (1,264 shares) |
| 2026-08-19 | Open-market sale (441 shares) |
| 2026-08-19 | Open-market sale (895 shares) |
| 2026-08-19 | Open-market sale (2,105 shares) |
| 2026-08-19 | Open-market sale (2,135 shares) |
| 2026-08-19 | Open-market sale (1,200 shares) |
| 2026-08-19 | Open-market sale (659 shares) |
| 2026-08-19 | Open-market sale (201 shares) |
| 2026-08-19 | Open-market sale (80 shares) |
| 2026-08-19 | Open-market sale (200 shares) |
| 2026-08-19 | Open-market sale (80 shares) |
| 2026-08-19 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.